Twist Bioscience (TWST) Restructuring Costs (2019 - 2026)

Twist Bioscience (TWST) posted quarterly Restructuring Costs of $7.2 million for Q1 2026, down 67.98% sequentially from $22.5 million in Q4 2019.

Twist Bioscience (TWST) Restructuring Costs (2019 - 2026) Analysis & Trends

Twist Bioscience has disclosed Restructuring Costs across 2 years of filings, most recently posting $7.2 million for Q1 2026.

  • In Q1 2026, Restructuring Costs changed N/A year-over-year to $7.2 million; the TTM figure through Mar 2026 stood at $7.2 million (changed N/A YoY), while the FY2020 annual figure was $22.5 million, changed N/A from the prior year.
  • Restructuring Costs retreated to $7.2 million in Q1 2026, from $22.5 million in the prior quarter.
  • Over the last five years, Restructuring Costs for TWST reached as high as $7.2 million in Q1 2026 and fell as low as $7.2 million in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Waters 31,055.11 Bn 31,054.65 Bn 1.11 Bn
2 Thermo Fisher Scientific 191.02 Bn 187.77 Bn 7.74 Bn
3 Danaher 137.16 Bn 131.47 Bn 3.59 Bn
4 Idexx Laboratories 42.82 Bn 42.62 Bn 722.74 Mn
5 Natera 39.09 Bn 37.99 Bn 696.04 Mn
6 Agilent Technologies 37.61 Bn 35.81 Bn 990.00 Mn
7 Iqvia Holdings 34.23 Bn 32.25 Bn 1.36 Bn
8 Illumina 28.14 Bn 26.98 Bn 721.00 Mn
9 Mettler Toledo International 26.40 Bn 26.33 Bn 555.82 Mn
10 Twist Bioscience 6.31 Bn 6.14 Bn 57.12 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 7.21 Mn
Dec 31, 2019 22.50 Mn